GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » FibroBiologics Inc (NAS:FBLG) » Definitions » YoY EBITDA Growth

FibroBiologics (FibroBiologics) YoY EBITDA Growth : -298.51% (As of Mar. 2024)


View and export this data going back to 2024. Start your Free Trial

What is FibroBiologics YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. FibroBiologics's YoY EBITDA Growth for the quarter that ended in Mar. 2024 was -298.51%.

FibroBiologics's EBITDA per Share for the three months ended in Mar. 2024 was $-0.27.

FibroBiologics YoY EBITDA Growth Historical Data

The historical data trend for FibroBiologics's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

FibroBiologics YoY EBITDA Growth Chart

FibroBiologics Annual Data
Trend Dec21 Dec22 Dec23
YoY EBITDA Growth
- -175.51 -262.22

FibroBiologics Quarterly Data
Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only - - -56.10 -697.30 -298.51

FibroBiologics YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

FibroBiologics's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (A: Dec. 2023 )
=(EBITDA per Share (A: Dec. 2023 )-EBITDA per Share (A: Dec. 2022 ))/ | EBITDA per Share (A: Dec. 2022 ) |
=(-0.489--0.135)/ | -0.135 |
=-262.22 %

FibroBiologics's YoY EBITDA Growth for the quarter that ended in Mar. 2024 is calculated as:

YoY EBITDA Growth (Q: Mar. 2024 )
=(EBITDA per Share (Q: Mar. 2024 )-EBITDA per Share (Q: Mar. 2023 )) / | EBITDA per Share (Q: Mar. 2023 )) |
=(-0.267--0.067)/ | -0.067 |
=-298.51 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

FibroBiologics YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of FibroBiologics's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

FibroBiologics (FibroBiologics) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » FibroBiologics Inc (NAS:FBLG) » Definitions » YoY EBITDA Growth
Comparable Companies
Traded in Other Exchanges
SG0:Germany
Address
455 E. Medical Center Boulevard, Suite 300, Houston, TX, USA, 77598
Website
https://www.fibrobiologics.com
FibroBiologics Inc is an early-stage, cell therapy company. Its primary focus is the initiation and progression of preclinical studies and clinical-stage FDA trials related to fibroblast treatments for Degenerative Disc Disease, Multiple Sclerosis, Cancer, Wound Healing, and other diseases.

FibroBiologics (FibroBiologics) Headlines

From GuruFocus

FibroBiologics Announces Three Japanese Patents on Fibroblast Technology

By PRNewswire • 02-12-2024

FibroBiologics Announces Three United States Patents for Fibroblast Technology

By PRNewswire • 02-12-2024